Skip to main content
Fig. 1 | Trials

Fig. 1

From: Salvage hypofractionated accelerated versus standard radiotherapy for the treatment of biochemical recurrence after radical prostatectomy (SHARE): the protocol of a prospective, randomized, open-label, superiority, multi-institutional trial

Fig. 1

Flowchart of study treatments. aRisk groups defined according to the National Comprehensive Cancer Network (NCCN) guidelines. PSA, prostate-specific antigen; HRT, hypofractionated radiotherapy; CRT, conventionally fractionated radiotherapy; IMRT, intensity-modulated radiotherapy; EQD2, equivalent dose in 2-Gy fractions

Back to article page

Trials

ISSN: 1745-6215